Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	-30.12	281.24	402.46
Graham Fair Price	32.97	16.03	12.06
PEG	inf	0.00	-5.42
Price/Book	-88.38	1.57	-13.49
Price/Cash Flow	-73.40	-21.59	81.17
Prices/Earnings	91.17	-31.03	-351.24
Price/Sales	-68.96	3.29	10.60
Price/FCF	-73.40	-21.59	81.17
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	330.58	0.42	0.10
Operating Margin	-197.72	-0.01	< 0.005
ROA	27.29	< 0.005	< 0.005
ROE	< 0.005	-0.01	31.50
ROIC	< 0.005	< 0.005	-139.34
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.00	-0.06	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.55	0.00	inf
EPS QOQ	0.65	0.00	inf
FCF QOQ	4.28	0.00	inf
Revenue QOQ	0.10	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	395.74	-903.18	128.22
Days Sales Outstanding (DSO)	56.44	24.03	-57.43
Inventory Turnover	0.23	-0.10	-56.18
Debt/Capitalization	1.42	0.48	-66.11
Quick Ratio	0.28	1.52	434.31
Naive Interpretation	member

04 - Leverage & Liquidity · Positive

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	-25.94	30.08	15.95
Cash	23.01	79.19	244.19
Capex	-0.49	-0.58	-16.22
Free Cash Flow	4.31	-2.18	-49.36
Revenue	33.02	14.33	-56.60
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	1.17	2.48	112.44
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	71.22	-972.92	1265.99
Naive Interpretation	Member

06 - Financial Health · Bad

Rating